Peritoneal Carcinomatosis in Colorectal Cancer: Review and Update of Current Clinical Data

被引：0
|
作者：
Blaj, S. [1 ]
Leebmann, H. [1 ]
Babucke, M. [1 ]
Acs, M. [2 ]
Piso, P. [1 ]
机构：
[1] Hosp Barmherzige Bruder Regensburg, Clin Gen & Visceral Surg, Regensburg, Germany
[2] Univ Hosp Regensburg, Clin Surg, Regensburg, Germany
来源：
CLINICAL COLORECTAL CANCER | 2024年 / 23卷 / 04期
关键词：
Clinical trials; Colorectal cancer; Cytoreductive surgery (CRS); Hyperthermic Intraperitoneal Chemotherapy (HIPEC); Peritoneal metastases; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; SYSTEMIC CHEMOTHERAPY; RANDOMIZED-TRIAL; HIGH-RISK; METASTASES; MANAGEMENT; THERAPY; METAANALYSIS; DIAGNOSIS;
D O I：
10.1016/j.clcc.2024.05.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The peritoneal metastasized colorectal cancer (pmCRC) represents a serious health problem worldwide with a special emphasis in the developed countries. Several guidelines recognize the role of multimodal therapy consisting of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of pmCRC. New data suggests that some other factors, eg, tumor biology, immune profile, neoadjuvant chemotherapy may play a predictive role for the oncological outcome of these patients. Clinical Colorectal Cancer, Vol. 23, No. 4, 309-317 (c) 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码：309 / 317
页数：9
相关论文
共 50 条
  • [21] Current role of hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from colorectal cancer
    Rampone, Bernardino
    Schiavone, Beniamino
    Martino, Antonio
    Confuorto, Giuseppe
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (11) : 1299 - 1302
  • [22] CLINICAL OUTCOME OF SYSTEMIC CHEMOTHERAPY FOR COLORECTAL PERITONEAL CARCINOMATOSIS
    Sasaki, Y.
    Hamaguchi, T.
    Yamada, Y.
    Shimada, Y.
    Kato, K.
    Iwasa, S.
    Honma, Y.
    ANNALS OF ONCOLOGY, 2012, 23 : 202 - 202
  • [23] Review of systemic chemotherapy in unresectable colorectal peritoneal carcinomatosis
    Nindra, Udit
    Shahnam, Adel
    Mahon, Kate L.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 (01) : 7 - 12
  • [24] Outcome of surgery for colorectal cancer in the presence of peritoneal carcinomatosis
    Klaver, Y. L. B.
    Lemmens, V. E. P. P.
    de Hingh, I. H. J. T.
    EJSO, 2013, 39 (07): : 734 - 741
  • [25] Role of Chemotherapy in Peritoneal Carcinomatosis in Metastatic Colorectal Cancer
    Franko, Jan
    Goldman, Charles D.
    Turaga, Kiran K.
    CURRENT COLORECTAL CANCER REPORTS, 2013, 9 (03) : 242 - 249
  • [26] Peritoneal carcinomatosis of colorectal origin - Incidence and current treatment strategies
    Koppe, MJ
    Boerman, OC
    Oyen, WJG
    Bleichrodt, RP
    ANNALS OF SURGERY, 2006, 243 (02) : 212 - 222
  • [27] RRAD expression in gastric and colorectal cancer with peritoneal carcinomatosis
    Hee Kyung Kim
    Inkyoung Lee
    Seung Tae Kim
    Jeeyun Lee
    Kyoung-Mee Kim
    Joon Oh Park
    Won Ki Kang
    Scientific Reports, 9
  • [28] RRAD expression in gastric and colorectal cancer with peritoneal carcinomatosis
    Kim, Hee Kyung
    Lee, Inkyoung
    Kim, Seung Tae
    Lee, Jeeyun
    Kim, Kyoung-Mee
    Park, Joon Oh
    Kang, Won Ki
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [29] Peritoneal carcinomatosis from colorectal cancer: treatment options
    Warrier, Satish K.
    Lynch, A. Craig
    COLORECTAL CANCER, 2013, 2 (05) : 441 - 447
  • [30] A curative approach to peritoneal carcinomatosis from colorectal cancer
    Sugarbaker, PH
    SEMINARS IN ONCOLOGY, 2005, 32 (06) : S68 - S73
12345